Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new Locations section listing study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Virginia) and included Revision: v3.3.3. Removed the previous state location blocks (Arizona Locations, California Locations, etc.) and the HHS Vulnerability Disclosure as part of Revision: v3.3.2.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded that publications are automatically filled from PubMed and shows the current revision (v3.3.2), and removed the previous PubMed publication description and old revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding notice has been removed from the page, and there are no changes to the study details or contact information.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions of note were detected on the Study Details page for NCT00954460; the content and layout remain consistent with the trial information.SummaryDifference0.2%

- Check84 days agoChange Detected- Added a government status notice and operating details, plus a link to official operating-status sources. - Updated version to v3.2.0 and removed the old v3.1.0 tag.SummaryDifference4%

- Check92 days agoChange DetectedUpdate: revision from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.